8-K: Bellevue Life Sciences Acquisition Corp. Secures $1.2 Million Loan from Sponsor

Bellevue Life Sciences Acquisition Corp. has obtained a $1.2 million promissory note from its sponsor, Bellevue Global Life Sciences Investors LLC, to support operations.

Summary

• Bellevue Life Sciences Acquisition Corp., a blank check company, received a $1.2 million promissory note from its sponsor, Bellevue Global Life Sciences Investors LLC.
• The note is unsecured and does not accrue interest.
• The principal is due on the earlier of December 31, 2024, or the date the company completes an initial business combination.
• The note can be prepaid at any time.
• If the company fails to complete a business combination by the deadline, the note will be forgiven, except for any funds held outside of the trust account.
• An event of default occurs if the company fails to pay the principal within five business days of the due date or if bankruptcy proceedings are initiated.
• The company also deposited $60,000 into its trust account to extend the business combination deadline from April 15, 2024, to May 14, 2024.

Sentiment

Score: 6

Explanation: The document indicates a standard financial transaction for a SPAC, with both positive (funding) and negative (reliance on sponsor, potential liquidation) aspects. The sentiment is neutral to slightly positive.

Positives

• The $1.2 million loan provides additional capital for the company's operations.
• The loan is non-interest bearing, reducing the company's financial burden.
• The forgiveness clause provides a safety net if a business combination is not completed.

Negatives

• The company is reliant on its sponsor for funding.
• Failure to complete a business combination could result in the loan being forgiven, indicating a potential failure of the company's primary objective.

Risks

• The company's ability to repay the loan is contingent on completing a business combination.
• Failure to complete a business combination by the extended deadline could lead to the loan being forgiven and the company potentially being liquidated.
• The company is dependent on the sponsor for funding, which may not always be available.

Future Outlook

The company's future is dependent on completing a business combination by May 14, 2024, or potentially by December 31, 2024, if the business combination is completed before then. Failure to do so could result in the loan being forgiven and the company potentially being liquidated.

Management Comments

• The company's CEO, Kuk Hyoun Hwang, signed the promissory note on behalf of Bellevue Life Sciences Acquisition Corp. and Bellevue Global Life Sciences Investors LLC.

Industry Context

This announcement is typical for a SPAC, which often relies on sponsor funding to cover operational costs while seeking a business combination. The extension of the deadline and the additional funding are common occurrences in the SPAC lifecycle.

Comparison to Industry Standards

• The terms of the promissory note, such as being non-interest bearing and having a forgiveness clause, are relatively standard for SPAC sponsor loans.
• The $1.2 million loan is within the typical range for SPAC funding needs prior to a business combination.
• The extension of the business combination deadline is also a common practice in the SPAC market, as many SPACs require additional time to find a suitable target.

Related Party Transactions

• The promissory note was issued to Bellevue Global Life Sciences Investors LLC, the sponsor of the company, which is a related party transaction.

Stakeholder Impact

• Shareholders are impacted by the extension of the business combination deadline and the potential for the company to be liquidated if a business combination is not completed.
• The sponsor is impacted by the potential forgiveness of the loan if a business combination is not completed.
• Creditors are impacted by the terms of the loan and the potential for default.

Next Steps

• The company needs to complete a business combination by May 14, 2024.
• The company may need to seek additional funding if the business combination is not completed by the deadline.

Key Dates

Keywords

promissory note, business combination, SPAC, financing, loan, trust account, sponsor, Bellevue Life Sciences Acquisition Corp.